Health Canada is expected to make a decision on the AstraZeneca/Oxford University COVID-19 vaccine any day, with an extra 1.1 million doses to be delivered by the end of March pending that approval. Several European nations are already discouraging its use among seniors, citing a lack of data.
On Friday, British regulators said they had received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine is effective in the elderly.
When asked about the efficacy in older adults the day before, Canada’s deputy chief public health officer Dr. Howard Njoo said that Health Canada will review the data as it becomes available.
Crystal Goomansingh has more.
For more info, please go to [ Ссылка ]
Subscribe to Global News Channel HERE: [ Ссылка ]
Like Global News on Facebook HERE: [ Ссылка ]
Follow Global News on Twitter HERE: [ Ссылка ]
Follow Global News on Instagram HERE: [ Ссылка ]
#GlobalNews
